Cody Simmons

Cody Simmons is the co-founder and CEO of DermaSensor, a Miami-based medical device company behind the first FDA-cleared, AI-powered handheld tool that helps primary care physicians evaluate skin lesions for cancer in seconds using elastic scattering spectroscopy. A bioengineer with a Brown degree, a Stanford master's and four years at Genentech, he took over the company in 2016 and spent nearly a decade shrinking a microwave-sized prototype into a point-and-click device, navigating FDA breakthrough designation, a De Novo clearance in early 2024, and a $16M Series B in 2025.